— Know what they know.
Not Investment Advice

MJARF OTC

MJardin Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -96.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $90140 mcap · 83M float · 0.0094% daily turnover

Balance Sheet Trends

Total Assets
$101M -38.2% ▼
5Y CAGR: +190.4%
Total Liabilities
$191M -14.9% ▼
5Y CAGR: +548.2%
Shareholders Equity
-$86M -50.9% ▼
Cash & Investments
$2M -84.9% ▼
5Y CAGR: +26.4%
Total Debt
$165M +15.2% ▲
Net Debt
$163M +22.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2016FY2017FY2018FY2019FY2020
— Assets —
Cash$397K$7M$30M$10M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$397K$7M$30M$10M$2M
Net Receivables$17K$751K$3M$6M$2M
Inventory$0$0$984K$665K$6M
Other Current Assets$0$64M$7M$58M$12M
Total Current Assets$413K$73M$47M$75M$23M
Property, Plant & Equip.$0$0$44M$43M$41M
Goodwill & Intangibles$0$0$166M$11M$11K
Long-Term Investments$0$0$39M$32M$36M
Other Non-Current Assets$0$0$409K$2M$0
Total Non-Current Assets$0$0$288M$88M$78M
Total Assets$413K$74M$336M$163M$101M
— Liabilities —
Accounts Payable$0$523K$8M$9M$6M
Short-Term Debt$0$30M$140M$27M$159M
Deferred Revenue$0$0$0$39M$0
Other Current Liabilities$27K$1M$7M$14M$18M
Total Current Liabilities$27K$33M$158M$104M$185M
Long-Term Debt$0$22M$276K$113M$2M
Other Non-Current Liab.$0$2M-$328K$3M$0
Total Non-Current Liabilities$0$25M$16M$120M$6M
Total Liabilities$27K$58M$174M$224M$191M
— Equity —
Common Stock$0$0$207M$251M$263M
Retained Earnings-$4M$0-$89M-$349M-$384M
Accumulated OCI$1M-$55K$4M$1M$3M
Total Stockholders Equity$386K$16M$165M-$57M-$86M
Total Liabilities & Equity$413K$74M$336M$163M$101M
— Key Metrics —
Total Debt$0$53M$143M$143M$165M
Net Debt-$397K$46M$113M$133M$163M
Total Investments$0$0$39M$32M$36M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms